abstract |
ANTI-CTLA4 BINDING PROTEINSnACTIVABLE MASKS. The invention provides anti-CTLA4 binding proteinsn activatable masking (e.g. antibodies, bispecific antibodiesn and chimeric receptors) and their use in the treatment and prevention of cancer,n as well as compositions and kits comprising the binding proteinsnactivatable masked anti-CTLA4. |